Vericiguat reduces cardiovascular death and heart failure (HF) hospitalization in high-risk patients with HF and reduced ejection fraction (HFrEF), but its non-invasive haemodynamic and remodelling effects in real-world practice remain incompletely characterized. We aimed to evaluate changes in non-invasive hemodynamic...
P. Bocchino, C. Carbonaro, G. Gallone et al.· American Journal of Cardiolo...· 1 citation
Current evidence on device-specific physiology, escalation and weaning, pulmonary vascular considerations, and post-transplant outcomes are summarized, and an integrated framework for individualized, trajectory-based decision-making is proposed.
Jorge A Ortega-Hernández, L. Baldetti, G. Gallone et al.· Current Heart Failure Report...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.